IMGN
Immunogen Inc
IMGN
IMGN
Delisted
IMGN was delisted on the 9th of February, 2024.
204 hedge funds and large institutions have $1.1B invested in Immunogen Inc in 2018 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 59 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
14% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 69
68% less call options, than puts
Call options by funds: $8.85M | Put options by funds: $27.5M
Holders
204
Holding in Top 10
1
Calls
$8.85M
Puts
$27.5M
Top Buyers
| 1 | +$57.9M | |
| 2 | +$39.1M | |
| 3 | +$17.6M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.36M |
| 5 |
Goldman Sachs
New York
|
+$7.34M |
Top Sellers
| 1 | -$16.4M | |
| 2 | -$15.7M | |
| 3 | -$14M | |
| 4 |
Millennium Management
New York
|
-$13.8M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$12.7M |